Successful treatment with eculizumab in a patient with pregnancy-associated atypical hemolytic uremic syndrome.

Duran, Mehmet Nuri; Beyazit, Fatma; Erbas, Mesut; Özkavak, Onur; Acar, Celal; Bakirdogen, Serkan

Duran, Mehmet Nuri; Beyazit, Fatma; Erbas, Mesut; Özkavak, Onur; Acar, Celal; Bakirdogen, Serkan.

Afiliação

Duran MN; Department of Obstetrics and Gynecology, Canakkale Onsekiz Mart University, Canakkale, Turkey.
Beyazit F; Department of Obstetrics and Gynecology, Canakkale Onsekiz Mart University, Canakkale, Turkey.
Erbas M; Department of Anesthesiology, Canakkale Onsekiz Mart University, Canakkale, Turkey.
Özkavak O; Department of Obstetrics and Gynecology, Canakkale Onsekiz Mart University, Canakkale, Turkey.
Acar C; Department of Hematology, Canakkale Onsekiz Mart University, Canakkale, Turkey.
Bakirdogen S; Department of Nephrology, Canakkale Onsekiz Mart University, Canakkale, Turkey.

Obstet Med ; 16(2): 130-133, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37441667

Palavras-chave

Atypical hemolytic uremic syndrome; eculizumab; hemolytic anaemia; kidney failure; plasma therapy; thrombocytopenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Obstet Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google